Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (131-140 of 278) with videos related to

Pageof 28
Sort By:
Blood|September 23, 2009
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaMarco Herling, Kaushali A Patel, Nicole Weit, et al.
Current Cancer Drug Targets|October 29, 2014
AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1Alexandra Schrader, Wagma Popal, Nils Lilienthal, et al.
The American Journal of Surgical Pathology|February 28, 2007
c-Jun expression and activation are restricted to CD30+ lymphoproliferative disordersElias Drakos, Vasiliki Leventaki, Ellen J Schlette, et al.
Blood|September 23, 2006
Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failureAlfonso Quintas-Cardama, Hagop Kantarjian, Dan Jones, et al.
American Journal of Clinical Pathology|April 22, 2005
EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipientC Cameron Yin, L Jeffrey Medeiros, Lynne V Abruzzo, et al.
Cancer|May 17, 2002
CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemiaJoseph D Khoury, L Jeffrey Medeiros, John T Manning, et al.
The American Journal of Dermatopathology|February 8, 2007
Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patientsSteve A May, Dan Jones, L Jeffrey Medeiros, et al.
Cancer Science|June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assaysC Cameron Yin, Jorge Cortes, John Galbincea, et al.
Stem Cells and Development|July 28, 2012
The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac diseaseAbdul M Mozid, Dan Jones, Samer Arnous, et al.
Nutrients|April 3, 2021
The Effectiveness of Smoking Cessation, Alcohol Reduction, Diet and Physical Activity Interventions in Improving Maternal and Infant Health Outcomes: A Systematic Review of Meta-AnalysesLouise Hayes, Catherine McParlin, Liane B Azevedo, et al.
Pageof 28

Showing results (131-140 of 278) with videos related to

Sort By:
Pageof 28
Blood|September 23, 2009
High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaMarco Herling, Kaushali A Patel, Nicole Weit, et al.
Current Cancer Drug Targets|October 29, 2014
AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1Alexandra Schrader, Wagma Popal, Nils Lilienthal, et al.
The American Journal of Surgical Pathology|February 28, 2007
c-Jun expression and activation are restricted to CD30+ lymphoproliferative disordersElias Drakos, Vasiliki Leventaki, Ellen J Schlette, et al.
Blood|September 23, 2006
Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failureAlfonso Quintas-Cardama, Hagop Kantarjian, Dan Jones, et al.
American Journal of Clinical Pathology|April 22, 2005
EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipientC Cameron Yin, L Jeffrey Medeiros, Lynne V Abruzzo, et al.
Cancer|May 17, 2002
CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemiaJoseph D Khoury, L Jeffrey Medeiros, John T Manning, et al.
The American Journal of Dermatopathology|February 8, 2007
Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patientsSteve A May, Dan Jones, L Jeffrey Medeiros, et al.
Cancer Science|June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assaysC Cameron Yin, Jorge Cortes, John Galbincea, et al.
Stem Cells and Development|July 28, 2012
The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac diseaseAbdul M Mozid, Dan Jones, Samer Arnous, et al.
Nutrients|April 3, 2021
The Effectiveness of Smoking Cessation, Alcohol Reduction, Diet and Physical Activity Interventions in Improving Maternal and Infant Health Outcomes: A Systematic Review of Meta-AnalysesLouise Hayes, Catherine McParlin, Liane B Azevedo, et al.
Pageof 28